SpectraCure AB (publ) (STO:SPEC)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0934
+0.0011 (1.19%)
Mar 9, 2026, 4:57 PM CET
-94.80%
Market Cap 53.29M
Revenue (ttm) n/a
Net Income (ttm) -53.17M
Shares Out 570.60M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 529,653
Average Volume 832,069
Open 0.0913
Previous Close 0.0923
Day's Range 0.0856 - 0.0939
52-Week Range 0.0840 - 2.2000
Beta 0.39
RSI 40.59
Earnings Date Feb 20, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 13
Stock Exchange Nasdaq Stockholm
Ticker Symbol SPEC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.